{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:41:03Z","timestamp":1783024863268,"version":"3.54.6"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.pathol.2020.09.033","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T08:07:50Z","timestamp":1624003670000},"page":"574-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Presence of corpora amylacea among prostate cancer cells: an unrecognised feature of intraductal carcinoma of the prostate"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3825-7971","authenticated-orcid":false,"given":"Miho","family":"Sugie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9219-8357","authenticated-orcid":false,"given":"Taishi","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0849-9665","authenticated-orcid":false,"given":"Akiko","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2424-6529","authenticated-orcid":false,"given":"Naoto","family":"Sassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyonori","family":"Tsuzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2020.09.033_bib1","first-page":"7","article-title":"Cancer statistics","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.pathol.2020.09.033_bib2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.eururo.2019.11.023","article-title":"Salvage radiotherapy versus hormone therapy for prostate-specific antigen failure after radical prostatectomy: a randomised, multicentre, open-label, phase 3 trial (JCOG0401)(\u2020)","volume":"77","author":"Yokomizo","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.033_bib3","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.eururo.2016.08.002","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer","volume":"71","author":"Cornford","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.033_bib4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/pros.22786","article-title":"Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens","volume":"74","author":"Kimura","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.pathol.2020.09.033_bib5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/modpathol.2015.146","article-title":"The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation","volume":"29","author":"Kato","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2020.09.033_bib6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s10147-017-1235-6","article-title":"Efficacy of docetaxel in castration-resistant prostate cancer patients with intraductal carcinoma of the prostate","volume":"23","author":"Yamamoto","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.pathol.2020.09.033_bib7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/bju.14970","article-title":"Propensity score-matched comparison of docetaxel and androgen receptor axis-targeted agents in patients with castration-resistant intraductal carcinoma of the prostate","volume":"125","author":"Yamamoto","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.pathol.2020.09.033_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/modpathol.3800050","article-title":"Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy","volume":"17","author":"Epstein","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2020.09.033_bib9","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/00000478-199607000-00003","article-title":"Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations","volume":"20","author":"McNeal","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.033_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/modpathol.3800250","article-title":"Corpora amylacea in adenocarcinoma of the prostate: incidence and histology within needle core biopsies","volume":"18","author":"Christian","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2020.09.033_bib11","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D'Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.pathol.2020.09.033_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.10657","article-title":"Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era","volume":"95","author":"D'Amico","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2020.09.033_bib13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJMoa1704174","article-title":"Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer","volume":"377","author":"Fizazi","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2020.09.033_bib14","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1073\/pnas.0810473106","article-title":"Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer","volume":"106","author":"Sfanos","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2020.09.033_bib15","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/pros.23692","article-title":"Corpora amylacea in prostatectomy tissue and associations with molecular, histological, and lifestyle factors","volume":"78","author":"DuPre","year":"2018","journal-title":"Prostate"},{"key":"10.1016\/j.pathol.2020.09.033_bib16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/pros.23980","article-title":"Corpora amylacea in benign prostatic acini are associated with concurrent, predominantly low-grade cancer","volume":"80","author":"Palangmonthip","year":"2020","journal-title":"Prostate"},{"key":"10.1016\/j.pathol.2020.09.033_bib17","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/1097-0142(19851001)56:7<1566::AID-CNCR2820560717>3.0.CO;2-Y","article-title":"Ductal spread in prostatic carcinoma","volume":"56","author":"Kovi","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2020.09.033_bib18","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0046-8177(98)90423-3","article-title":"Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer","volume":"29","author":"Wilcox","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2020.09.033_bib19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/00000478-199807000-00006","article-title":"Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications","volume":"22","author":"Rubin","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.033_bib20","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.eururo.2009.10.020","article-title":"Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classification","volume":"57","author":"Efstathiou","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2020.09.033_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00428-019-02574-0","article-title":"Dataset for the reporting of prostate carcinoma in radical prostatectomy specimens: updated recommendations from the International Collaboration on Cancer Reporting","volume":"475","author":"Kench","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2020.09.033_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pathol.2018.10.003","article-title":"Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"51","author":"Egevad","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2020.09.033_bib23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamaoncol.2018.6760","article-title":"Prevalence of germline variants in prostate cancer and implications for current genetic testing guidelines","volume":"5","author":"Nicolosi","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.pathol.2020.09.033_bib24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/his.13747","article-title":"Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set","volume":"74","author":"Masoomian","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.09.033_bib25","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/PAS.0000000000001104","article-title":"Comedonecrosis revisited: strong association with intraductal carcinoma of the prostate","volume":"42","author":"Fine","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.033_bib26","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 international society of urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.09.033_bib27","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/jcp.45.10.894","article-title":"Amyloid in prostatic corpora amylacea","volume":"45","author":"Cross","year":"1992","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2020.09.033_bib28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0090-4295(74)90490-7","article-title":"Infection stones of prostate gland. Laboratory diagnosis and clinical management","volume":"4","author":"Meares","year":"1974","journal-title":"Urology"},{"key":"10.1016\/j.pathol.2020.09.033_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00256894","article-title":"Lactoferrin in human prostate tissue","volume":"9","author":"van Sande","year":"1981","journal-title":"Urol Res"},{"key":"10.1016\/j.pathol.2020.09.033_bib30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/iju.12657","article-title":"Intraductal carcinoma of the prostate: a comprehensive and updated review","volume":"22","author":"Tsuzuki","year":"2015","journal-title":"Int J Urol"},{"key":"10.1016\/j.pathol.2020.09.033_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/path.4628","article-title":"Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization","volume":"238","author":"Haffner","year":"2016","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2020.09.033_bib32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41568-019-0231-8","article-title":"Outcompeting cancer","volume":"20","author":"Vishwakarma","year":"2020","journal-title":"Nat Rev Cancer"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130252100235X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130252100235X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:26:37Z","timestamp":1758471997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003130252100235X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S003130252100235X"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2020.09.033","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presence of corpora amylacea among prostate cancer cells: an unrecognised feature of intraductal carcinoma of the prostate","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2020.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}